IgGenix (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- February 06, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $40,000,000
Company Info
- Founders
- Stephen Quake, Kari Nadeau, Derek Croote
- Company Description
- IgGenix is a biotechnology company.
- Market
- Allergy treatment
- Location
- South San Francisco, California, USA
- Coinvestors
- Alexandria Venture Investments, AllerFund, Eli Lilly and Company, Sean Parker